Anticorps Recombinant de lapin anti-TFPI

TFPI Recombinant Antibody for Cytometric bead array, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

Cytometric bead array, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

240977F12

N° de cat : 83838-4-PBS

Synonymes

EPI, Extrinsic pathway inhibitor, LACI, Lipoprotein-associated coagulation inhibitor, TFI



Informations sur le produit

83838-4-PBS cible TFPI dans les applications de Cytometric bead array, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène TFPI Protéine recombinante Eg0855
Nom complet tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
Masse moléculaire calculée35 kDa
Poids moléculaire observé 40-45 kDa
Numéro d’acquisition GenBankNM_006287.6
Symbole du gène TFPI
Identification du gène (NCBI) 7035
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Tissue factor pathway inhibitor (TFPI) is a critical anticoagulant protein present in endothelium and platelets. TFPI is produced as two major isoforms in humans, TFPIa and TFPIb that result from alternative splicing. The TFPIb isoform localizes to the endothelium surface where it is a potent inhibitor of tissue factor-factor VIIa complexes that initiate blood coagulation. The TFPIa isoform is present in platelets. TFPI is a Kunitz-type serine protease inhibitor that exerts anticoagulant activity by blocking early procoagulant stimulia. TFPI can enhance anti-thrombotic treatment in sepsis, inflammatory diseases, and cardiovascular diseases.

{{ptg:RelatedPrimaryAntibodies}}